PULSE BIOSCIENCES INC NASDAQ:​PLSE

Was targeted by Citron shorts. Due for recovery if earnings well perceived by market.

Watching for a buying opportunity in the $13 range, with a target of $27

PLSE has been bleeding cash for a while now but it has attracted investments from two investors providing cash infusion to help it stay afloat on early February. This is when the stock broke out and has been trending up since then. Even though doom and gloom was predicted for PLSE here on Feb 23 2017 stock has moved up by $7 since then. Yesterday I was expecting a...

Was looking to take this short under $9.00 level.... HAHAHAHAHAH